Showing results (1-10 of 499) with videos related to
Sort By:
Pageof 50
Open Forum Infectious Diseases|July 21, 2025
Examining Pricing and Availability for Neglected Tropical Disease Therapies in the United StatesMaple Goh, Kevin Outterson, Aaron S KesselheimHealth Affairs Scholar|February 19, 2026
Priority without progress: the FDA's neglected tropical disease voucher program after 18 yearsMaple Goh, Kevin Outterson, Aaron S KesselheimEclinicalmedicine|September 24, 2025
Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27Maple Goh, Matt McEnany, Rachel Freeman, et al.Plos Medicine|September 30, 2025
Whose burden, whose benefit? Revisiting ethical trade-offs in the WHO guidelines on scaling up mass azithromycin administrationMaple Goh, A M Viens, Safura Abdool Karim, et al.Health Affairs (Project Hope)|September 8, 2010
Fighting antibiotic resistance: marrying new financial incentives to meeting public health goalsAaron S Kesselheim, Kevin OuttersonHealth Affairs (Project Hope)|August 1, 2009
How Medicare could get better prices on prescription drugsKevin Outterson, Aaron S KesselheimHealth Affairs (Project Hope)|January 9, 2008
Market-based licensing for HPV vaccines in developing countriesKevin Outterson, Aaron S KesselheimThe Journal of Antimicrobial Chemotherapy|November 19, 2025
The curious constraints on clofazimineMaple Goh, Daniel Eisenkraft Klein, Aaron S KesselheimAnnals of Internal Medicine|May 31, 2016
Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration-Approved Antibiotics, 2010-2015Dalia Deak, Kevin Outterson, John H Powers, et al.The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 4, 2013
Approval and withdrawal of new antibiotics and other antiinfectives in the U.S., 1980-2009Kevin Outterson, John H Powers, Enrique Seoane-Vazquez, et al.Pageof 50